SCHEMBL26041582

SCHEMBL26041582

Cc1cc(C(=O)O)c(N)c(Br)c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.53
KMT2A Q03164 3/20 0.44
MEN1 O00255 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
GABRP O00591 2/20 0.42
GABRD O14764 2/20 0.42
GABRA1 P14867 2/20 0.42
GABRB1 P18505 2/20 0.42
GABRG2 P18507 2/20 0.42
GABRB3 P28472 2/20 0.42
GABRA5 P31644 2/20 0.42
GABRA3 P34903 2/20 0.42
GABRA2 P47869 2/20 0.42
GABRB2 P47870 2/20 0.42
GABRA4 P48169 2/20 0.42
GABRE P78334 2/20 0.42
GABRA6 Q16445 2/20 0.42
GABRG1 Q8N1C3 2/20 0.42
GABRG3 Q99928 2/20 0.42
GABRQ Q9UN88 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28051617 0.86 KDM4E (0.60) KDM4EKMT2AMEN1TDP1GABRP
SCHEMBL27565198 0.85 KDM4E (0.53) KDM4EKMT2AMEN1TDP1GABRP
SCHEMBL1291691 0.85 KDM4E (0.48) KDM4EKMT2AMEN1TDP1GABRP
SCHEMBL31423245 0.85 KDM4E (0.53) KDM4EKMT2AMEN1TDP1GABRP
SCHEMBL27871751 0.82 KDM4E (0.55) KDM4EKMT2AMEN1TDP1GABRP
SCHEMBL5094605 0.82 KDM4E (0.59) KDM4EKMT2AMEN1TDP1GABRP
SCHEMBL28482651 0.82 KDM4E (0.59) KDM4EKMT2AMEN1TDP1GABRP
SCHEMBL24988644 0.81 KDM4E (0.50) KDM4EKMT2AMEN1TDP1GABRP
SCHEMBL31322677 0.81 KDM4E (0.46) KDM4EKMT2AMEN1TDP1GABRP
SCHEMBL31403094 0.81 KDM4E (0.46) KDM4EKMT2AMEN1TDP1GABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed
WO-2023159155-A1 INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) AND USES THEREOF PIVALENT THERAPEUTICS, INC. (US) 2023-08-24 WO disclosed
CN-105848483-A Quinolinyl modulators of roryt 詹森药业有限公司 2016-08-10 CN disclosed
CN-105829295-A Phenyl Linked Quinolinyl Modulators Of Ror-Gamma-T 詹森药业有限公司 2016-08-03 CN disclosed